Cannabinoid hyperemesis syndrome (CHS) is a syndrome of cyclic vomiting associated with
cannabis use. Our objective is to summarize the available evidence on CHS diagnosis …

Cannabis sativa is an aromatic annual flowering plant with several botanical varieties, used
for different purposes, like the production of fibers, the production of oil from the seeds, and …

The actions of cannabis are mediated by receptors that are part of an endogenous
cannabinoid system. The endocannabinoid system (ECS) consists of the naturally occurring …

Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric
infections and inflammatory conditions to disorders of motility, emesis and abdominal pain …

Food intake is detected by the chemical senses of taste and smell and subsequently by
chemosensory cells in the gastrointestinal tract that link the composition of ingested foods to …

Background Cannabinoids are used by patients with inflammatory bowel disease (IBD) to
alleviate their symptoms. Little is known on patient motivation, benefit, or risks of this …

Chronic constipation is a common gastrointestinal disorder, with a worldwide incidence of
14–30%. It negatively affects quality of life and is associated with a considerable economic …

Objectives Cannabis-based medicinal products (CBMPs) have shown promising preclinical
activity in inflammatory bowel disease (IBD). However, clinical trials have not demonstrated …

Endogenous cannabinoid signalling is widespread throughout the body, and considerable
evidence supports its modulatory role in many fundamental physiological processes. The …

Anecdotal and scientific evidence suggests that Cannabis use may be beneficial in
inflammatory bowel disease (IBD) patients. Here, we have investigated the effect of a …